Accord

GEMCITABINE

Manufacturer:

Accord

Gemcitabine HCPCS:

J9196

HCPCS Code Descriptor:

Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

Category:

J Code

Gemcitabine NDCs:

16729-0391-30, 68001-0342-34, 16729-0419-03, 68001-0348-36, 16729-0423-33, 68001-0359-37, 16729-0426-05

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Gemcitabine CPT Codes:

Potential CPT administration codes for Gemcitabine can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gemcitabine:

GEMCITABINE is an Oncology drug manufactured by Accord and administered via the Intravenous route of administration. The J Code: J9196 is aligned to the drug GEMCITABINE.

ACCESS PRICING AND MORE BY REGISTERING

J9196 Added Date:

April 1, 2023

J9196 Effective Date:

April 1, 2023

J9196 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Gemcitabine billing and coding information.
Our team did not identify a source for Gemcitabine patient assistance information. Please reach out to our team if you feel that this is a mistake.
GEMCITABINE prescribing information can be found at the link below:
Information regarding GEMCITABINE’s side effects can be found at MedlinePlus